Lung cancer drug helps majority in study
Key points
- An experimental drug to treat lung cancer appeared to benefit two-thirds of patients who used it, according to a study presented on Friday by manufacturer Telik Inc., pushing shares up as much as 17 percent.
- The compound, Telcyta, aims to treat non-small cell lung cancer, one of the deadliest and poorly treated types of cancer.
- Among 13 patients who took the medication along with a standard chemotherapy combination, seven experienced a partial response, and one patient had a complete response.
- Results were presented at the American Society of Clinical Oncology meeting in Orlando, Florida.
An experimental drug to treat lung cancer appeared to benefit two-thirds of patients who used it, according to a study presented on Friday by manufacturer Telik Inc., pushing shares up as much as 17 percent.
The compound, Telcyta, aims to treat non-small cell lung cancer, one of the deadliest and poorly treated types of cancer.
Among 13 patients who took the medication along with a standard chemotherapy combination, seven experienced a partial response, and one patient had a complete response.
Results were presented at the American Society of Clinical Oncology meeting in Orlando, Florida.
Shares were up 35 cents, or 2.1 percent, at $17.35 in afternoon Nasdaq trade after rising as high as $19.87 earlier in the session.
Written and revised by
David Cohen, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Cancer →
NewsNew hope for ways to overcome drug resistance in lung cancer
Scientists have suggested it may be possible to reverse drug resistance in lung cancer patients, thereby improving the effectiveness of chemotherapy, according to research published in the EMBO Journal. Most lung cancer…
15 July 2006
NewsLung cancer slowed by Pfizer drug
A Pfizer Inc. kidney cancer drug has also shown promise in a small mid-stage trial as a treatment for the most common form of lung cancer, researchers said on Saturday. The new study involved 63 patients whose non-small…
6 June 2006
NewsGene test helps predict lung cancer, study finds
A test that finds damaged genes in the lungs of people considered at high risk of lung cancer might be able to predict who actually develops the deadly disease, U.S. researchers said on Wednesday. The test is still not…
17 March 2006
